Gene therapy trial launched for X-linked retinitis pigmentosa – ModernMedicine
|
Gene therapy trial launched for X-linked retinitis pigmentosa
ModernMedicine Researchers have injected their first patient with a virus engineered to remodel the gene responsible for X-linked retinitis pigmentosa (XLRP). “If successful, this gene therapy has the potential to transform the lives of many patients,” said David … |
